Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2023-05-03 00:00:00 ET · period of report 2023-04-25 · accession 0001104659-23-055529 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-04-25 | INSP | Jandrich Steven | VP, Human Resources | M - OptEx | $42.15 | +8,000 | 12.4K | +183% | +$337.2K |
| DM | 2023-05-03 | 2023-04-25 | INSP | Jandrich Steven | VP, Human Resources | S - Sale+OE | $271.02 | -8,000 | 4,371 | -65% | -$2.17M |
| D | 2023-05-03 | 2023-04-25 | INSP | Jandrich Steven | VP, Human Resources | M - OptEx | $0.00 | -8,000 | 5,432 | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-25 | M | A | 8,000 | $42.15 | 12,371 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-25 | S | D | 5,499 | $270.24 | 6,872 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.78, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-04-25 | S | D | 401 | $271.20 | 6,471 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.08 to $271.49, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2023-04-25 | S | D | 2,100 | $273.03 | 4,371 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.00 to $273.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-04-25 | M | D | 8,000 | $0.00 | 5,432 | D | $42.15 · — to 2028-12-18 | 8,000 Common Stock | (F5) The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |